Source:http://linkedlifedata.com/resource/pubmed/id/21127908
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2011-4-12
|
pubmed:abstractText |
We carried out the first simulation on multi-stage continuous high cell density culture (MSC-HCDC) to show that the MSC-HCDC can achieve batch/fed-batch product titer with much higher productivity to the fed-batch productivity using published fermentation kinetics of lactic acid, penicillin and ethanol. The system under consideration consists of n-serially connected continuous stirred-tank reactors (CSTRs) with either hollow fiber cell recycling or cell immobilization for high cell-density culture. In each CSTR substrate supply and product removal are possible. Penicillin production is severely limited by glucose metabolite repression that requires multi-CSTR glucose feeding. An 8-stage C-HCDC lactic acid fermentation resulted in 212.9 g/L of titer and 10.6 g/L/h of productivity, corresponding to 101 and 429% of the comparable lactic acid fed-batch, respectively. The penicillin production model predicted 149% (0.085 g/L/h) of productivity in 8-stage C-HCDC with 40 g/L of cell density and 289% of productivity (0.165 g/L/h) in 7-stage C-HCDC with 60 g/L of cell density compared with referring batch cultivations. A 2-stage C-HCDC ethanol experimental run showed 107% titer and 257% productivity of the batch system having 88.8 g/L of titer and 3.7 g/L/h of productivity. MSC-HCDC can give much higher productivity than batch/fed-batch system, and yield a several percentage higher titer as well. The productivity ratio of MSC-HCDC over batch/fed-batch system is given as a multiplication of system dilution rate of MSC-HCDC and cycle time of batch/fed-batch system. We suggest MSC-HCDC as a new production platform for various fermentation products including monoclonal antibody.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Culture Media,
http://linkedlifedata.com/resource/pubmed/chemical/Ethanol,
http://linkedlifedata.com/resource/pubmed/chemical/Glucose,
http://linkedlifedata.com/resource/pubmed/chemical/Lactic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Penicillins
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1615-7605
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
34
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
419-31
|
pubmed:meshHeading |
pubmed-meshheading:21127908-Antibodies, Monoclonal,
pubmed-meshheading:21127908-Biomass,
pubmed-meshheading:21127908-Bioreactors,
pubmed-meshheading:21127908-Chemistry, Pharmaceutical,
pubmed-meshheading:21127908-Computer Simulation,
pubmed-meshheading:21127908-Culture Media,
pubmed-meshheading:21127908-Ethanol,
pubmed-meshheading:21127908-Fermentation,
pubmed-meshheading:21127908-Glucose,
pubmed-meshheading:21127908-Kinetics,
pubmed-meshheading:21127908-Lactic Acid,
pubmed-meshheading:21127908-Models, Statistical,
pubmed-meshheading:21127908-Penicillins,
pubmed-meshheading:21127908-Substrate Specificity,
pubmed-meshheading:21127908-Technology, Pharmaceutical,
pubmed-meshheading:21127908-Time Factors
|
pubmed:year |
2011
|
pubmed:articleTitle |
Multi-stage high cell continuous fermentation for high productivity and titer.
|
pubmed:affiliation |
Department of Chemical and Biomolecular Engineering, KAIST (Korea Advanced Institute of Science and Technology), Daejeon, Korea. hnchang@kaist.edu
|
pubmed:publicationType |
Journal Article
|